feed,title,long_url,short_url
SeekingAlpha,Cognizant shares slide as Q4 results fall short,https://seekingalpha.com/news/3658116,
SeekingAlpha,argenx rise even as Immunovant pauses the trial for anti-FcRn therapy,https://seekingalpha.com/news/3658115,
